These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22056993)

  • 21. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
    Fletcher PJ; Rizos Z; Noble K; Soko AD; Silenieks LB; Lê AD; Higgins GA
    Neuropharmacology; 2012 Jun; 62(7):2288-98. PubMed ID: 22342986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
    Liégeois JF; Ichikawa J; Meltzer HY
    Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute treatment with fluvoxamine elevates rat brain serotonin synthesis in some terminal regions: an autoradiographic study.
    Muck-Seler D; Pivac N; Diksic M
    Nucl Med Biol; 2012 Oct; 39(7):1053-7. PubMed ID: 22560971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice.
    Pozzi L; Greco B; Sacchetti G; Leoni G; Invernizzi RW; Carli M
    Psychopharmacology (Berl); 2010 Feb; 208(3):387-99. PubMed ID: 19997843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
    Ferguson MC; Nayyar T; Ansah TA
    Neurochem Int; 2014 May; 71():36-46. PubMed ID: 24704796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.
    Knauer CS; Campbell JE; Galvan B; Bowman C; Osgood S; Buist S; Buchholz L; Henry B; Wong EH; Shahid M; Grimwood S
    Eur J Pharmacol; 2008 Sep; 591(1-3):136-41. PubMed ID: 18593577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective 5-HT1B receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study.
    Hasegawa S; Watanabe A; Nishi K; Nguyen KQ; Diksic M
    Neurochem Int; 2005 Feb; 46(3):261-72. PubMed ID: 15670643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
    Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
    Agnoli L; Carli M
    Psychopharmacology (Berl); 2012 Jan; 219(2):633-45. PubMed ID: 22113450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both acute and subchronic treatments with pindolol, a 5-HT(1A) and β₁ and β₂ adrenoceptor antagonist, elevate regional serotonin synthesis in the rat brain: an autoradiographic study.
    Skelin I; Fikre-Merid M; Diksic M
    Neurochem Int; 2012 Dec; 61(8):1417-23. PubMed ID: 23084984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic D-fenfluramine treatments have different effects on serotonin synthesis rates in the rat brain: an autoradiographic study.
    Yamane F; Tohyama Y; Diksic M
    Neurochem Res; 1999 Dec; 24(12):1611-20. PubMed ID: 10591413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.
    Gozzi A; Crestan V; Turrini G; Clemens M; Bifone A
    Psychopharmacology (Berl); 2010 Mar; 209(1):37-50. PubMed ID: 20111859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.
    Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Hutson PH
    Psychopharmacology (Berl); 2009 Nov; 206(4):641-51. PubMed ID: 19707745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.